The report also details steps that employers are taking to manage the cost of healthcare plans for employees.
A new report from global insurance brokerage, risk management, and consulting firm Arthur J. Gallagher & Co. details how well employers in the U.S. believe that they are effectively managing their healthcare costs.1 Due to a variety of factors, such as rising health plan premiums, medical services, and specialty drugs, only about half of the employers surveyed said they felt that they were effectively managing these costs.
According to Gallagher, one of the main areas of concern is the cost of GLP-1 drugs, which have recently become very popular for people looking to lose or manage their weight.
In a press release, Gallagher’s CEO of its benefits and HR consulting division William F. Ziebell said, “The advantages of new treatments for obesity and excess weight are evident, but the significant cost associated with these medications cannot be ignored. Employers that successfully navigate this challenge tend to take a mindful approach to their benefits design. For example, they may require an employee clear a body mass index threshold and actively participate in an employer-sponsored wellbeing program before they cover GLP-1 prescription costs. A holistic strategy, such as this, will likely result in better outcomes, as well as improved employee engagement."
Ziebell continues, “It's important for decision-makers to understand the diverse needs of their workforce and use this as a guide to create a benefits offering that will appeal to them. Where many employers fall short is by failing to communicate when and how to use specific benefits, and their value. By ensuring that employees are well-informed and equipped with the necessary information to utilize their available benefits, employers can improve employee engagement and bolster retention."
While the cost of health insurance is a significant concern for business owners, it’s also worth noting that business owners seem to be concerned about insurance costs in general. In August of last year, Gallagher released the details of a report that covered wider insurance concerns.2 According to that report, business owners were concerned about specific events that could cause serious financial harm to the business. Many business owners expressed a desire for more coverage, despite that extra cost.
In a press release issued at the time, Gallagher’s CEO J. Patrick Gallagher, Jr. said, “Our goal is to position our clients for success, always striving for the best solutions, whether they be disaster recovery, employee wellness or claims outcomes. The findings from this survey are proof points of what we hear every day in speaking with our clients: 'These are my fears, how can you help?' We provide tailored risk management for their specific needs to instill confidence and offer the peace of mind business owners need to navigate the complexities of today's business environment."
He continued, “The big take-away from this survey is just how much insurance can help business owners. At the end of the day, business owners worry about how their business can support their family. Gallagher understands that–we are a family-driven business, and we work with companies of all sizes to lessen risk and make sure owners can continue operating and ultimately, providing for their families.”
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
FDA Grants Priority Review to GSK’s Gepotidacin for Uncomplicated Urinary Tract Infections
October 18th 2024Priority Review status for GSK’s New Drug Application for gepotidacin was based on promising results from the Phase III EAGLE-2 and EAGLE-3 trials, which demonstrated non-inferiority to nitrofurantoin in uncomplicated urinary tract infections.